News & Updates
Filter by Specialty:
Low-dose semaglutide spurs MASLD regression in people with HIV
21 Mar 2024
byJairia Dela Cruz
Treatment with low-dose semaglutide helps reduce the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with HIV, according to data from the single-arm phase IIb ACTG A5371 trial.
Low-dose semaglutide spurs MASLD regression in people with HIV
21 Mar 2024
Antidepressants improve cognition in people with late-life depression
19 Mar 2024
Use of antidepressant medication may lead to improvements in some areas of cognitive function, such as memory and learning, in individuals with late-life depression (LLD), a study has shown.